Not checked for notices yet.
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
Paal F. Brunsvig, Tormod Kyrre Guren, Marta Nyakas and 7 more
Frontiers in Immunology · 2020
Cited by papers we hold 1
- GM-CSF: A Double-Edged Sword in Cancer Immunotherapy · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.